"Sifting through puddles from the firehose of last week’s American Society of Clinical Oncology annual meeting brought to my attention some promising news from the world of ovarian cancer," writes David Kroll.
"This early efficacy study with a synthetic drug based on a naturally-occurring molecule also demonstrates the continued value of prospecting the planet to harvest chemical diversity for the relief of human suffering."
Read David's analysis of the marine-derived drug for cancer, Yondelis® (trabectedin, ET-743), developed by Spain's PharmaMar SA and already approved for ovarian cancer patients in the European Union and Japan.
Writing in Slate, Cathy “Weapons of Math Destruction” O’Neill, a skeptical data-scientist, describes the ways that Big Data intersects with ethical considerations.
Our pals at surreal clothiers Imaginary Foundation bring us this fine enamel pin emblazoned with an essential insight of the ages, captured by a simple Venn diagram. Just $10!
In his weekly address, President Barack Obama this week pledged $4 billion in federal funding for computer science education in schools throughout the nation.
Remember back to the time when people thought java was just a hip way to talk about coffee? Or you vaguely remembered from geography class that it’s an island in the South Pacific? We’ve come a long way since then and now that we’ve rocket blasted into the tech future, you’re going to need to […]
Plastic is so 2013. You don’t want to buy something only to throw it away or lose it and barely care. You like nice things and want to hang onto them. The Plazmatic lighter here is a high quality, high tech alternative to the typical cheap, plastic lighter you get at the old gas station. […]
Real engineers build things. Super cool engineers build things with their hands and fingers, like our engineering forefathers did. No idea where to even begin to do that? This step by step Arduino course is now 92% off and is going to get you up and running, from zero to hero, in no time. So […]